Performance of RMD ResMed | -10.4% in 12m
Compare RMD with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare ResMed with its related Sector/Index XLV
Performance Duell RMD vs XLV
| TimeFrame | RMD | XLV |
|---|---|---|
| 1 Day | -5.42% | 0.56% |
| 1 Week | -3.01% | 1.41% |
| 1 Month | 5.63% | 2.64% |
| 3 Months | -9.44% | 7.56% |
| 6 Months | 4.12% | 8.49% |
| 12 Months | -10.4% | 13.60% |
| YTD | 15.3% | 8.87% |
| Rel. Perf. 1m | 0.51 | |
| Rel. Perf. 3m | 0.28 | |
| Rel. Perf. 6m | -0.07 | |
| Rel. Perf. 12m | -0.07 |
Is ResMed a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, ResMed (NYSE:RMD) is currently (July 2024)
a good stock to buy. It has a ValueRay Fundamental Rating of 90.20 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RMD as of July 2024 is 168.69. This means that RMD is currently overvalued and has a potential downside of -14.39% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RMD as of July 2024 is 168.69. This means that RMD is currently overvalued and has a potential downside of -14.39% (Sold with Premium).
Is RMD a buy, sell or hold?
- Strong Buy: 5
- Buy: 4
- Hold: 6
- Sell: 0
- Strong Sell: 0
Values above 0%: RMD is performing better - Values below 0%: RMD is underperforming
Compare RMD with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -2.18% | 5.83% | -8.29% | -31.03% |
| US NASDAQ 100 | QQQ | -0.43% | 9.25% | -5.44% | -31.94% |
| US Dow Jones Industrial 30 | DIA | -3.76% | 1.82% | -3.34% | -26.71% |
| German DAX 40 | DBXD | -4.40% | 4.19% | -3.98% | -25.30% |
| UK FTSE 100 | ISFU | -4.20% | 3.02% | -7.43% | -25.61% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.01% | 5.93% | 2.00% | 5.15% |
| Hongkong Hang Seng | HSI | -1.59% | 6.41% | 8.12% | 9.57% |
| Japan Nikkei 225 | EXX7 | -1.50% | 6.78% | 2.58% | -21.35% |
| India NIFTY 50 | INDA | -4.15% | 2.73% | -11.39% | -37.38% |
| Brasil Bovespa | EWZ | -2.08% | 4.24% | 18.25% | 1.96% |
RMD ResMed vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.35% | 8.26% | -4.21% | -33.37% |
| Consumer Discretionary | XLY | -0.24% | 6.02% | -2.71% | -16.38% |
| Consumer Staples | XLP | -3.52% | 4.02% | -5.57% | -17.12% |
| Energy | XLE | -2.82% | 3.86% | -7.07% | -19.35% |
| Financial | XLF | -4.32% | -0.20% | -9.06% | -35.43% |
| Health Care | XLV | -4.42% | 2.99% | -4.37% | -24.04% |
| Industrial | XLI | -4.16% | 1.84% | -7.95% | -26.67% |
| Materials | XLB | -4.36% | 2.54% | -7.50% | -19.15% |
| Real Estate | XLRE | -3.55% | -2.24% | -3.50% | -20.93% |
| Technology | XLK | -0.93% | 10.03% | -3.45% | -32.65% |
| Utilities | XLU | -4.49% | 2.17% | -14.06% | -20.19% |
| Aerospace & Defense | XAR | -6.65% | -0.06% | -10.96% | -30.17% |
| Biotech | XBI | -7.14% | -4.51% | -11.10% | -31.07% |
| Homebuilder | XHB | -7.30% | -10.37% | -19.69% | -49.78% |
| Retail | XRT | -5.10% | 3.00% | -6.99% | -25.93% |
Does ResMed outperform its market, is RMD a Sector Leader?
No, over the last 12 months ResMed (RMD) made -10.44%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.60%.
Over the last 3 months RMD made -9.44%, while XLV made 7.56%.
No, over the last 12 months ResMed (RMD) made -10.44%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 13.60%.
Over the last 3 months RMD made -9.44%, while XLV made 7.56%.
| Period | RMD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 5.63% | 2.64% | -0.20% |
| 3 Months | -9.44% | 7.56% | 7.46% |
| 12 Months | -10.44% | 13.60% | 20.59% |